Webinar

Changing Patterns of Care in Multiple Myeloma

Current therapeutic options for multiple myeloma and best practices in dispensing medications throughout the COVID-19 pandemic.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Screenshot of an interview with Nicolas Girard, MD, PhD
Byoung Chul Cho, MD, PhD
Beth Stein, MD, and Ratna Kiran Bhavaraju-Sanka, MD
Related Content
AJMC commentary
September 16th 2025

Overcoming Weight Bias in Health Care Systems

Theodore K. Kyle, RPh, MBA Fatima Cody Stanford, MD, MPH, MPA, MBA W. Timothy Garvey, MD Julia P. Dunn, MD, MSc Ximena Ramos Salas, PhD
Managed Care Cast Logo
September 16th 2025

AI in Health Care: Balancing Governance, Innovation, and Trust

Maggie L. Shaw Reuben Daniel
The iRR6 may help identify those who are unlikely to derive long-term benefit from ruxolitinib and could be considered for alternative therapies. | Image credit: mdaros - stock.adobe.com
September 16th 2025

Refined iRR6 Model Improves Risk Stratification in Intermediate-1 Myelofibrosis

Kimberly Rath, PharmD
managed care cast logo
September 16th 2025

Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA

Brooke McCormick Richard A. Brook, MS, MBA
Global upward trend | Image credit: Philip Steury – stock.adobe.com
September 16th 2025

Global MASH Burden Projected to Double Costs, Raise Mortality Without Intervention

Hayden E. Klein
340B PVP spedning increased by nearly $37 million dollars from 2010 to 2021 due to eligibility expanision and market trends. | Image Credit: @onephoto - stock.adobe.com.jpeg
September 16th 2025

340B Program Spending Increases Due to Market Trends and Eligibility Expansion

Sabrina McCrear

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo